Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 8, pp. 2122-2130
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 9, 2009
- Revision received April 9, 2009
- Accepted April 29, 2009
- Published first July 28, 2009.
Article Versions
- Previous version (July 28, 2009 - 09:08).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 American Association for Cancer Research.
Author Information
- Zhenfeng Duan1,
- Edwin Choy2,3,
- David Harmon2,3,
- Cao Yang1,
- Keinosuke Ryu1,
- Joseph Schwab1,
- Henry Mankin1 and
- Francis J. Hornicek1
- 1Center for Sarcoma and Connective Tissue Oncology, 2MGH Cancer Center, and 3Department of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts
- Requests for reprints:
Zhenfeng Duan, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Jackson Building, Room 1115, 55 Fruit Street, Boston, MA 02114. Phone: 617-724-3144; Fax: 617-724-7396. E-mail: zduan{at}partners.org
Z. Duan and E. Choy contributed equally to this work.
August 2009
Volume 8, Issue 8
Volume 8, Issue 8
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines
Jump to section
Advertisement